— Know what they know.
/
Not Investment Advice
Also trades as: 0UNL.L (LSE) · $vol 0M

NKTR NASDAQ

Nektar Therapeutics
1W: +2.2% 1M: -34.4% 3M: -47.1% YTD: -13.8% 1Y: -41.1% 3Y: +362.4% 5Y: -84.7%
$37.97
+0.52 (+1.39%)
After Hours: $38.12 (+0.16, +0.41%)
Weekly Expected Move ±13.7%
$27 $32 $37 $42 $47
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $1.1B mcap · 29M float · 3.87% daily turnover · Short 50% of daily vol
Credit Risk of going bust: higher than 66% of companies Debt: 11.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.56 (down 99%), Nektar Therapeutics would be worth roughly what it owes.
Total debt $135.9M against a stock market value of $1.07B.
Distance to default 3.71 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $51.4M (short-term plus half of long-term), stock volatility 79.9%; Altman Z'' -3.33. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
42.3 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -29.2%
Cost Advantage
42
Intangibles
51
Switching Cost
43
Network Effect
47
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NKTR shows a Weak competitive edge (42.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -29.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$50
Low
$96
Avg Target
$150
High
Based on 4 analysts since Aug 13, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 22Hold: 6Sell: 5Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$95.75
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-12 Leerink Partners Will Soghikian Initiated $130 — +215.8% $41.17
2026-10-12 UBS Alice Nettleton Initiated $53 — +28.7% $41.17
2026-10-01 Jefferies Roger Song $121 $150 +29 +219.2% $46.99
2026-09-23 Wedbush — $80 $50 -30 -18.0% $60.97
2026-07-22 Canaccord Genuity Edward Nash Initiated $153 — +122.8% $68.67
2026-05-11 Wedbush Martin Fan $95 $80 -15 -2.3% $81.89
2026-05-08 Piper Sandler Yasmeen Rahimi $105 $192 +87 +130.3% $83.37
2026-04-21 Wedbush — Initiated $95 — -6.5% $101.64
2026-04-20 H.C. Wainwright — $165 $185 +20 +73.3% $106.75
2026-03-13 Oppenheimer Jay Olson $115 $140 +25 +91.1% $73.27
2026-02-10 BTIG — Initiated $151 — +190.4% $52.00
2026-02-10 H.C. Wainwright — $135 $165 +30 +213.6% $52.62
2026-01-26 Piper Sandler Yasmeen Rahimi Initiated $105 — +188.9% $36.35
2025-12-16 H.C. Wainwright — Initiated $135 — +163.8% $51.17
2025-12-16 Oppenheimer Jay Olson Initiated $115 — +128.0% $50.43
2025-11-24 Jefferies Roger Song $99 $121 +22 +122.9% $54.28
2025-09-18 Jefferies Roger Song Initiated $99 — +68.5% $58.74
2022-04-17 Mizuho Securities Mara Goldstein Initiated $6 — +26.6% $4.74
2022-02-28 J.P. Morgan Jessica Fye Initiated $17 — +54.8% $10.98
2021-11-07 Ladenburg Thalmann & Co. Aydin Huseynov Initiated $20 — +36.5% $14.65
2021-05-17 Goldman Sachs Chris Shibutani Initiated $24 — +32.4% $18.13

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NKTR receives an overall rating of C. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-12 C- C
2026-10-01 C C-
2026-08-14 C- C
2026-05-08 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 22 Grade D
Profitability
20
Balance Sheet
62
Earnings Quality
50
Growth
12
Value
38
Momentum
20
Safety
65
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NKTR scores highest in Safety (65/100) and lowest in Growth (12/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.67
Grey Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✗ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
2.90
Possible Manipulator
Ohlson O-Score
-6.68
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB-
Score: 53.9/100
Trend: Improving
Earnings Quality
—
OCF/NI: 1.49x
Accruals: 11.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NKTR scores 2.67, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NKTR scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NKTR's score of 2.90 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NKTR's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NKTR receives an estimated rating of BBB- (score: 53.9/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-5.67x
PEG
-0.59x
P/S
19.98x
P/B
1.39x
P/FCF
-9.86x
P/OCF
—
EV/EBITDA
-13.11x
EV/Revenue
32.23x
EV/EBIT
-13.04x
EV/FCF
-7.52x
Earnings Yield
-6.81%
FCF Yield
-10.14%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NKTR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.002
NI / EBT
×
Interest Burden
1.162
EBT / EBIT
×
EBIT Margin
-2.472
EBIT / Rev
×
Asset Turnover
0.084
Rev / Assets
×
Equity Multiplier
1.482
Assets / Equity
=
ROE
-35.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NKTR's ROE of -35.8% is driven by Asset Turnover (0.084), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$37.97
Median 1Y
$18.16
5th Pctile
$3.12
95th Pctile
$106.38
Ann. Volatility
96.8%
Analyst Target
$95.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Howard W. Robin
President and Chief Executive Officer
 $1,106,282 $942,081 $6,256,954
Jonathan Zalevsky, Ph.D.
Chief Research and Development Officer
 $717,560 $271,750 $2,320,358
Sandra Gardiner Interim
Chief Financial Officer
 $— $— $686,400
Mark A. Wilson
Former Chief Legal Officer
 $645,950 $— $667,901

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,256,954
Avg Employee Cost (SGA/emp): $1,090,048
Employees: 63

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
63
+3.3% YoY
Revenue / Employee
$876,698
Rev: $55,232,000
Profit / Employee
$-2,604,381
NI: $-164,076,000
SGA / Employee
$1,090,048
Avg labor cost proxy
R&D / Employee
$1,862,381
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -50.2% -59.6% -61.3% -77.0% -74.8% -70.4% -97.7% -93.6% -1.0% -1.1% -95.7% -1.3% -1.6% -1.2% -1.9% -4.4% -1.8% -2.2% -53.6% -35.8% -35.75%
ROA -35.6% -39.4% -39.6% -47.0% -44.1% -40.3% -52.3% -45.3% -48.0% -49.8% -36.7% -42.3% -44.9% -33.9% -40.8% -44.4% -39.6% -56.2% -31.0% -24.1% -24.12%
ROIC -13.0% -4.0% -4.3% 14.5% -504.5% 27.7% 2.3% 2.4% 2.3% 3.8% 2.7% -4.6% 1.4% 90.4% 86.4% 76.6% 83.0% 14.8% -65.4% -29.2% -29.22%
ROCE -39.3% -46.1% -48.9% -64.6% -60.9% -52.3% -76.5% -62.5% -67.9% -72.4% -44.1% -53.3% -59.7% -37.6% -54.6% -65.6% -37.3% -57.8% -18.0% -13.2% -13.17%
Gross Margin 78.7% 75.4% 78.6% 76.3% 79.0% 71.7% 67.3% 65.9% 48.5% 69.5% 60.6% 58.5% 81.6% 72.7% 1.0% 1.0% 98.3% 1.0% 98.6% 1.0% 1.00%
Operating Margin -4.6% -4.5% -4.6% -2.2% -1.6% -1.9% -6.2% -2.5% -1.9% -1.4% -1.6% -2.1% -1.4% 49.2% -4.3% -3.2% -2.7% -87.5% -3.5% -4.2% -4.18%
Net Margin -5.2% -5.8% -3.6% -7.4% -2.5% -2.7% -6.3% -2.5% -1.9% -1.8% -1.7% -2.2% -1.5% 24.9% -4.9% -3.7% -3.0% -1.7% -4.1% -4.0% -4.01%
EBITDA Margin -4.5% -5.4% -3.2% -6.9% -2.1% -2.1% -5.9% -2.1% -1.6% -1.4% -1.4% -1.9% -1.2% 59.9% -3.9% -3.0% -2.5% -1.2% -3.4% -4.2% -4.15%
FCF Margin -3.7% -4.2% -4.3% -4.5% -4.3% -3.4% -3.0% -2.8% -2.3% -2.1% -2.1% -1.9% -1.9% -1.8% -2.0% -2.5% -3.0% -3.8% -3.7% -4.3% -4.29%
OCF Margin -3.6% -4.0% -4.1% -4.3% -4.2% -3.3% -3.0% -2.8% -2.3% -2.1% -2.1% -1.9% -1.9% -1.8% -2.0% -2.5% -3.0% -3.8% -3.7% -4.3% -4.28%
ROA 3Y Avg snapshot only -41.61%
ROIC Economic snapshot only -9.99%
Cash ROA snapshot only -21.35%
Cash ROIC snapshot only -65.91%
CROIC snapshot only -65.98%
NOPAT Margin snapshot only -1.90%
Pretax Margin snapshot only -2.87%
R&D / Revenue snapshot only 2.41%
SGA / Revenue snapshot only 97.65%
SBC / Revenue snapshot only 21.95%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -6.67 -4.77 -2.04 -1.35 -1.32 -1.16 -0.32 -0.36 -0.39 -0.39 -1.03 -1.46 -1.62 -1.67 -1.08 -2.98 -6.64 -5.23 -11.26 -14.69 -5.675
P/S Ratio 32.95 24.52 9.72 7.37 6.32 4.62 1.49 1.25 1.28 1.20 2.02 2.78 2.92 2.02 1.64 4.86 12.80 15.54 31.99 42.27 19.981
P/B Ratio 4.13 3.68 1.65 1.55 1.46 1.16 0.55 0.56 0.71 0.82 1.44 3.25 5.56 3.27 10.44 -15.04 9.42 9.55 3.09 2.56 1.392
P/FCF -8.92 -5.84 -2.28 -1.65 -1.47 -1.37 -0.49 -0.45 -0.55 -0.56 -0.96 -1.48 -1.53 -1.12 -0.80 -1.96 -4.21 -4.11 -8.73 -9.86 -9.859
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -5.84 -4.12 -1.09 -0.48 -0.46 -0.16 0.53 0.65 0.54 0.32 -0.05 -1.42 -0.99 -0.53 -0.26 -3.26 -7.20 -5.85 -10.76 -13.11 -13.105
EV/Revenue 25.23 18.72 4.63 2.39 1.99 0.56 -2.21 -1.99 -1.56 -0.86 0.07 2.23 1.46 0.47 0.29 3.79 9.96 13.78 24.35 32.23 32.225
EV/EBIT -5.66 -4.01 -1.06 -0.47 -0.44 -0.15 0.51 0.63 0.52 0.31 -0.04 -1.36 -0.95 -0.50 -0.25 -3.18 -7.10 -5.80 -10.69 -13.04 -13.038
EV/FCF -6.83 -4.46 -1.08 -0.53 -0.46 -0.17 0.73 0.71 0.68 0.40 -0.04 -1.18 -0.76 -0.26 -0.14 -1.53 -3.27 -3.65 -6.64 -7.52 -7.516
Earnings Yield -15.0% -21.0% -49.0% -73.9% -75.6% -86.6% -3.1% -2.8% -2.6% -2.6% -96.7% -68.4% -61.9% -59.9% -92.8% -33.6% -15.1% -19.1% -8.9% -6.8% -6.81%
FCF Yield -11.2% -17.1% -44.0% -60.6% -68.1% -72.8% -2.0% -2.2% -1.8% -1.8% -1.0% -67.7% -65.4% -89.2% -1.2% -51.1% -23.7% -24.3% -11.5% -10.1% -10.14%
Price/Tangible Book snapshot only 2.555
EV/Gross Profit snapshot only 32.432
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 7.05 9.34 6.97 6.34 7.14 8.00 8.20 8.70 7.66 6.45 6.10 5.15 4.24 4.26 3.24 2.61 4.24 4.97 10.21 10.42 10.416
Quick Ratio 6.94 9.15 6.82 6.18 6.91 7.72 7.86 8.29 7.37 6.14 5.79 4.90 4.24 4.26 3.24 2.61 4.24 4.97 10.21 10.42 10.416
Debt/Equity 0.18 0.21 0.23 0.30 0.33 0.36 0.53 0.63 0.76 0.90 0.90 2.76 2.21 1.69 7.30 -3.97 1.08 1.66 0.25 0.15 0.151
Net Debt/Equity -0.97 -0.87 -0.86 -1.05 -1.00 -1.02 -1.36 -1.45 -1.58 -1.42 -1.38 -0.65 -2.79 -2.51 -8.61 — -2.10 -1.08 -0.74 -0.61 -0.607
Debt/Assets 0.11 0.13 0.14 0.16 0.17 0.19 0.23 0.25 0.27 0.30 0.29 0.64 0.35 0.34 0.39 0.46 0.31 0.53 0.19 0.12 0.124
Debt/EBITDA -0.34 -0.31 -0.33 -0.29 -0.33 -0.41 -0.34 -0.47 -0.47 -0.48 -0.79 -1.50 -0.79 -1.18 -1.02 -1.10 -1.06 -1.14 -1.14 -1.01 -1.013
Net Debt/EBITDA 1.79 1.28 1.20 1.01 1.00 1.15 0.88 1.06 0.98 0.76 1.21 0.35 0.99 1.76 1.21 0.91 2.06 0.74 3.38 4.09 4.085
Interest Coverage -9.44 -10.06 -10.81 -13.70 -14.22 -11.62 -13.82 -10.38 -10.33 -9.90 -6.20 -6.17 -5.78 -3.24 -3.67 -3.36 -3.30 -5.01 -4.35 -4.36 -4.358
Equity Multiplier 1.59 1.64 1.68 1.88 1.89 1.94 2.33 2.51 2.77 3.04 3.13 4.31 6.30 5.00 18.65 -8.57 3.54 3.12 1.32 1.21 1.213
Cash Ratio snapshot only 9.641
Debt Service Coverage snapshot only -4.335
Cash to Debt snapshot only 5.034
FCF to Debt snapshot only -1.722
Defensive Interval snapshot only 1356.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.07 0.08 0.08 0.09 0.09 0.10 0.11 0.13 0.14 0.16 0.19 0.22 0.25 0.28 0.27 0.27 0.21 0.19 0.11 0.08 0.084
Inventory Turnover 1.63 1.60 1.52 1.39 1.25 1.24 1.31 1.34 1.91 1.91 1.93 2.16 3.96 3.81 2.73 1.72 — — — — —
Receivables Turnover 2.79 3.32 3.47 4.96 4.69 6.47 5.35 15.47 12.85 25.08 27.27 73.61 43.05 69.96 32.73 58.84 36.69 32.60 20.94 17.88 17.878
Payables Turnover 1.18 1.56 1.40 1.37 1.49 1.90 2.87 3.38 7.59 2.96 5.66 8.35 5.06 2.87 1.67 1.20 0.68 0.02 0.02 0.02 0.018
DSO 131 110 105 74 78 56 68 24 28 15 13 5 8 5 11 6 10 11 17 20 20.4 days
DIO 223 228 240 263 291 295 278 272 191 191 189 169 92 96 134 213 0 0 0 0 0.0 days
DPO 310 234 262 267 245 192 127 108 48 123 64 44 72 127 219 305 539 20792 14653 20602 20602.0 days
Cash Conversion Cycle 44 104 84 70 124 160 219 188 171 82 138 130 28 -26 -74 -86 -529 -20781 -14635 -20582 -20581.6 days
Fixed Asset Turnover snapshot only 12.817
Cash Velocity snapshot only 0.080
Capital Intensity snapshot only 20.061
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -38.5% -33.4% -18.2% -8.7% -5.3% -9.7% -13.8% -8.9% -7.1% -2.1% 1.5% 6.2% 5.5% 9.2% -3.2% -19.6% -32.8% -43.9% -36.2% -27.2% -27.15%
Net Income -12.7% -17.9% -14.6% -10.7% 8.3% 29.7% 15.6% 41.5% 35.3% 25.0% 57.6% 42.3% 42.7% 56.9% 24.3% 31.0% 28.3% -37.9% -18.8% -28.5% -28.51%
EPS -9.7% -14.5% -11.8% -8.2% 10.0% 30.9% 16.9% 42.4% 36.3% 26.1% 58.9% 47.6% 47.9% 61.5% 30.1% 31.8% 29.0% 3.2% 32.4% 45.2% 45.23%
FCF -6.2% -33.4% -36.9% -33.9% -10.3% 27.6% 38.8% 42.9% 50.0% 37.5% 29.8% 28.5% 13.0% 8.4% 5.8% -6.1% -7.1% -17.8% -14.5% -25.8% -25.78%
EBITDA -13.2% -17.9% -15.4% -14.1% 4.9% 30.0% 14.4% 43.7% 37.8% 24.9% 61.3% 45.5% 46.3% 64.3% 32.2% 40.2% 37.2% -50.1% -28.5% -53.8% -53.75%
Op. Income -17.2% -17.4% -12.7% 10.4% 29.7% 46.1% 42.5% 32.1% 13.2% -9.8% 36.7% 38.0% 43.5% 60.1% 30.5% 38.4% 36.0% -24.9% -9.5% -30.2% -30.23%
OCF Growth snapshot only -26.43%
Asset Growth snapshot only 4.28%
Debt Growth snapshot only 41.37%
Shares Change snapshot only 1.35%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -56.8% -56.0% -55.7% -6.8% -7.6% -7.0% -13.4% -18.6% -18.5% -16.2% -10.6% -4.1% -2.5% -1.2% -5.4% -8.0% -13.0% -15.7% -14.4% -14.6% -14.63%
Revenue 5Y -9.7% -9.2% -4.7% -6.3% -17.6% -21.4% -22.7% -42.3% -41.1% -40.3% -40.2% -4.8% -5.0% -3.0% -8.6% -14.3% -17.5% -18.4% -15.1% -12.3% -12.34%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y -60.2% -59.6% -59.2% -8.3% -9.1% -8.9% -17.7% -23.9% -26.9% -25.0% -19.3% -12.4% -6.5% -4.2% -6.1% -5.6% -9.5% -7.9% -5.5% -4.6% -4.60%
Gross Profit 5Y -10.6% -10.6% -5.4% -6.5% -19.9% -24.0% -25.7% -45.9% -46.1% -45.5% -45.7% -10.6% -8.4% -6.2% -11.1% -15.1% -17.5% -16.2% -12.0% -8.0% -7.97%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y -17.2% -19.6% -22.1% -25.7% -28.0% -28.9% -33.2% -32.3% -33.6% -36.3% -35.2% -37.0% -37.8% -35.2% -37.0% -37.8% -27.2% -26.7% 10.8% 30.4% 30.37%
Assets 5Y 24.6% 14.5% 14.1% 12.6% 6.1% 6.9% 2.5% -26.6% -27.8% -28.6% -28.8% -30.4% -31.8% -31.2% -32.9% -33.5% -27.5% -28.9% -12.1% -4.4% -4.40%
Equity 3Y -23.5% -26.6% -28.1% -33.5% -34.8% -36.1% -42.9% -46.1% -48.6% -50.5% -49.7% -55.5% -60.6% -55.3% -71.7% — -40.9% -37.4% 33.7% 66.1% 66.13%
Book Value 3Y -25.1% -28.2% -29.7% -34.9% -36.3% -37.5% -44.1% -47.2% -49.6% -51.5% -50.9% -57.4% -62.3% -57.4% -72.9% — -43.2% -46.7% 6.8% 20.6% 20.60%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.07 0.07 0.06 0.24 0.77 0.76 0.83 0.70 0.71 0.70 0.69 0.87 0.83 0.63 0.85 0.81 0.85 0.82 0.87 0.84 0.842
Earnings Stability 0.19 0.23 0.18 0.31 0.37 0.34 0.34 0.39 0.35 0.30 0.24 0.43 0.58 0.69 0.73 0.74 0.85 0.83 0.78 0.83 0.826
Margin Stability 0.90 0.90 0.90 0.95 0.93 0.92 0.92 0.87 0.84 0.83 0.83 0.88 0.90 0.90 0.88 0.85 0.86 0.81 0.82 0.81 0.810
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.95 0.93 0.94 0.96 0.97 0.88 0.94 0.83 0.86 0.90 0.50 0.83 0.83 0.50 0.90 0.88 0.89 0.85 0.92 0.89 0.886
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.29 -0.41 -0.42 -0.71 -0.61 -0.41 -1.10 -0.72 -0.98 -1.22 -0.12 -0.87 -1.97 -0.40 -8.13 — 1.22 0.21 5.26 — —
Gross Margin Trend -0.07 -0.09 -0.08 -0.05 -0.05 -0.05 -0.06 -0.06 -0.14 -0.14 -0.14 -0.15 -0.02 -0.01 0.07 0.18 0.22 0.34 0.32 0.28 0.280
FCF Margin Trend -1.16 -1.60 -1.73 -1.81 -1.39 -0.22 0.38 0.96 1.68 1.63 1.55 1.75 1.40 0.96 0.52 -0.14 -0.93 -1.80 -1.60 -2.10 -2.105
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.73 0.79 0.86 0.79 0.88 0.83 0.64 0.80 0.69 0.70 1.07 0.99 1.05 1.48 1.33 1.51 1.57 1.27 1.29 1.49 1.488
FCF/OCF 1.03 1.04 1.04 1.03 1.03 1.02 1.01 1.01 1.01 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 1.490
CapEx/Revenue 10.8% 14.7% 15.8% 14.3% 11.6% 6.2% 2.1% 1.5% 1.3% 1.0% 0.7% 0.7% 1.3% 1.5% 1.5% 1.6% 1.0% 0.3% 0.3% 0.5% 0.48%
CapEx/Depreciation snapshot only 0.378
Accruals Ratio -0.10 -0.08 -0.05 -0.10 -0.05 -0.07 -0.19 -0.09 -0.15 -0.15 0.03 -0.01 0.02 0.16 0.13 0.23 0.23 0.15 0.09 0.12 0.118
Sloan Accruals snapshot only 0.848
Cash Flow Adequacy snapshot only -892.321
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.6% 1.2% 1.1% 1.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.0% -1.3% -1.6% -0.7% -0.4% -0.1% -0.4% -0.1% -0.1% -0.0% -14.9% -10.4% -9.9% -13.6% -0.0% -0.1% -17.7% -21.0% -39.9% -46.6% -46.60%
Total Shareholder Return -1.0% -1.3% -1.6% -0.7% -0.4% -0.1% -0.4% -0.1% -0.1% -0.0% -14.9% -10.4% -9.9% -13.6% -0.0% -0.1% -17.7% -21.0% -39.9% -46.6% -46.60%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.002
Interest Burden (EBT/EBIT) 1.11 1.10 1.09 1.07 1.07 1.09 1.07 1.10 1.10 1.10 1.16 1.16 1.17 1.31 1.32 1.37 1.38 1.25 1.25 1.16 1.162
EBIT Margin -4.46 -4.67 -4.36 -5.07 -4.46 -3.65 -4.32 -3.16 -3.00 -2.78 -1.68 -1.64 -1.54 -0.93 -1.16 -1.19 -1.40 -2.38 -2.28 -2.47 -2.472
Asset Turnover 0.07 0.08 0.08 0.09 0.09 0.10 0.11 0.13 0.14 0.16 0.19 0.22 0.25 0.28 0.27 0.27 0.21 0.19 0.11 0.08 0.084
Equity Multiplier 1.41 1.51 1.55 1.64 1.70 1.75 1.87 2.07 2.14 2.23 2.61 3.03 3.60 3.66 4.64 9.93 4.55 3.88 1.73 1.48 1.482
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-40.36 $-42.48 $-39.65 $-42.14 $-36.31 $-29.34 $-32.94 $-24.27 $-23.13 $-21.68 $-13.54 $-12.72 $-12.06 $-8.35 $-9.46 $-8.68 $-8.57 $-8.08 $-6.39 $-4.75 $-4.75
Book Value/Share $65.30 $55.11 $49.06 $36.84 $32.95 $29.22 $19.13 $15.58 $12.55 $10.28 $9.76 $5.72 $3.50 $4.27 $0.98 $-1.72 $6.04 $4.43 $23.29 $27.32 $27.32
Tangible Book/Share $59.07 $48.90 $42.89 $30.69 $26.84 $23.12 $19.13 $15.58 $12.55 $10.28 $9.76 $5.72 $3.50 $4.27 $0.98 $-1.72 $6.04 $4.43 $23.29 $27.32 $27.32
Revenue/Share $8.18 $8.26 $8.32 $7.74 $7.60 $7.34 $7.05 $6.94 $6.95 $7.08 $6.94 $6.69 $6.68 $6.91 $6.20 $5.32 $4.44 $2.72 $2.25 $1.65 $1.65
FCF/Share $-30.19 $-34.68 $-35.54 $-34.52 $-32.69 $-24.68 $-21.40 $-19.40 $-16.10 $-15.19 $-14.57 $-12.60 $-12.75 $-12.44 $-12.67 $-13.21 $-13.51 $-10.28 $-8.24 $-7.08 $-7.08
OCF/Share $-29.31 $-33.47 $-34.22 $-33.41 $-31.80 $-24.23 $-21.24 $-19.30 $-16.01 $-15.12 $-14.52 $-12.55 $-12.66 $-12.34 $-12.58 $-13.13 $-13.47 $-10.27 $-8.24 $-7.07 $-7.07
Cash/Share $75.04 $59.52 $53.84 $49.73 $43.68 $40.24 $36.28 $32.38 $29.36 $23.84 $22.28 $19.48 $17.53 $17.92 $15.55 $12.49 $19.18 $12.11 $22.99 $20.70 $20.70
EBITDA/Share $-35.31 $-37.55 $-35.19 $-38.20 $-32.94 $-25.81 $-29.64 $-21.18 $-20.21 $-19.09 $-11.12 $-10.49 $-9.88 $-6.09 $-6.97 $-6.20 $-6.15 $-6.41 $-5.09 $-4.06 $-4.06
Debt/Share $11.93 $11.61 $11.48 $11.20 $10.76 $10.48 $10.18 $9.87 $9.55 $9.25 $8.79 $15.77 $7.76 $7.20 $7.14 $6.83 $6.52 $7.34 $5.80 $4.11 $4.11
Net Debt/Share $-63.11 $-47.91 $-42.36 $-38.53 $-32.91 $-29.76 $-26.10 $-22.52 $-19.80 $-14.59 $-13.49 $-3.71 $-9.77 $-10.72 $-8.41 $-5.66 $-12.66 $-4.77 $-17.19 $-16.59 $-16.59
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.670
Altman Z-Prime snapshot only 4.347
Piotroski F-Score 1 1 2 3 4 3 3 4 4 3 2 3 3 3 3 4 4 2 3 3 3
Beneish M-Score -3.60 -3.44 -2.90 -3.97 -3.52 -3.72 -5.19 -4.20 -4.34 -4.40 14.83 5.17 -2.29 -1.75 -3.28 -2.23 -1.81 -1.95 0.19 2.90 2.896
Ohlson O-Score snapshot only -6.681
ROIC (Greenblatt) snapshot only -20.06%
Net-Net WC snapshot only $16.56
EVA snapshot only $-139135990.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB-
Credit Score 34.97 29.30 30.34 30.78 31.31 31.80 29.70 29.71 30.23 29.88 30.33 25.43 25.34 26.64 22.39 20.00 27.88 26.51 31.59 53.91 53.910
Credit Grade snapshot only 10
Credit Trend snapshot only 33.910
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 51
Sector Credit Rank snapshot only 46

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms